Cannabidiol (CBD) is a chemical compound largely produced by hemp, a plant from the cannabis family. However, unlike the marijuana plant, hemp is not intoxicating because it usually contains little to no levels of the psychotropic compound delta-9 tetrahydrocannabinol (THC). CBD’s main claim to fame is that it is said to have potent medical properties. Initial studies have found that the compound may be able to alleviate chronic pain, anxiety and insomnia, among other things.
Cannabidiol has grown exceedingly popular in recent years due to its purported medical benefits coupled with the fact that it can be consumed in a variety of different form factors. However, despite the runaway popularity of CBD products, the CBD market is barely regulated.
While some states have legalized CBD products, federal law still outlaws CBD-infused products such as sodas, cold brew coffee and sparkling water. The result is a patchwork of state-level CBD laws for a market that is already estimated to be worth hundreds of millions of dollars.
Federal prohibition has also proven to be a challenge to the CBD-infused segments, with some experts saying that it may be a while before we see CBD-infused food products in major stores such as Target or Walmart.
Although CBD became legal when the 2018 farm bill legalized the cultivation and sale of industrial hemp and its extracts, federal law has outlawed CBD-infused foods. This is because CBD is an active ingredient in Epidiolex, a medication that is used to treat seizures in pediatric epilepsy. As per federal law, cannabidiol cannot be infused into dietary supplements and foods for interstate trade because it has been used as an active ingredient in an approved drug.
The Ohio State University College of Medicine internal medicine professor Dr. Harrison Weed states that this makes it much harder to lace foodstuffs with medications. However, while the FDA’s approval of Epidiolex was historic, it essentially made the cannabis-infused food segment illegal at the federal level. THC is also illegal at the federal level partly because it is used as an ingredient in FDA-approved drugs Syndros and Marinol.
At the moment, Weed notes that the regulatory agency could use its authority to regulate CBD- and THC-infused products. The FDA’s only actions so far regarding the cannabis-infused foodstuffs segment have been to send warning letters to companies that were selling CBD-infused food products.
Center for Medical Cannabis Education founder and medical director Jamie Corroon stated that the FDA is still unsure of the safety of CBD as a dietary supplement and food additive.
It is this regulatory gray area at the federal level that is also making it difficult for cannabis companies to access banking services, although a number of innovative companies, including REZYFi Inc., are coming up with ways to avail the funding that marijuana-industry players need to sustain and even grow their enterprises.
NOTE TO INVESTORS: The latest news and updates relating to REZYFi, Inc. are available in the company’s newsroom at https://cnw.fm/REZY
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.
